Investors

Insider Transactions

Date Name Title Type Shares Traded Sorted Descending Price Range
Feb 21, 2014 sing george l Director Option Execute 15,000 15.80
Feb 20, 2015 sing george l Director Sell 15,000 423.12
Feb 20, 2015 sing george l Director Option Execute 15,000 18.61
Feb 14, 2014 sing george l Director Sell 15,000 324.00
Aug 6, 2014 van plew daniel p Officer Option Execute 15,000 21.25
Aug 1, 2012 powchik peter Officer Option Execute 14,990 15.64 - 21.92
Apr 3, 2009 vagelos p roy Director Disposition (Non Open Market) 14,976 n/a
Feb 14, 2014 terifay robert j Officer Disposition (Non Open Market) 14,930 323.30
Feb 17, 2011 goldberg murray a Officer Option Execute 14,850 19.43
Jan 18, 2011 roberts william Officer Automatic Sell 14,720 34.88 - 34.99
Sep 29, 2008 stahl neil Officer Disposition (Non Open Market) 14,683 23.28
Jul 17, 2014 brown michael s Director Disposition (Non Open Market) 14,662 n/a
Jul 17, 2014 brown michael s Director Acquisition (Non Open Market) 14,662 n/a
Dec 3, 2012 goldberg murray a Officer Disposition (Non Open Market) 14,500 n/a
Dec 3, 2012 goldberg murray a Officer Acquisition (Non Open Market) 14,500 n/a
Apr 30, 2012 van plew daniel p Officer Sell 14,442 135.94 - 136.42
Sep 8, 2011 goldberg murray a Officer Automatic Sell 14,258 72.60
Dec 31, 2014 powchik peter Officer Automatic Sell 14,178 412.78
Sep 1, 2009 roberts william Officer Automatic Sell 14,166 23.49
Sep 1, 2009 roberts william Officer Option Execute 14,166 8.50
Showing 361-380 of 974 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.



Close
Form content here please :)